FDA: Datscan: A Radiopharmaceutical and Parkinson Disease
The Wall Street Journal's HealthBlog discusses this radiopharmaceutical and the FDA meeting to be held tomorrow about it [read post here]
Labels: clinical trials, neurodegenerative, neuroimaging, Parkinson, radiopharmaceutical
posted by Anthony Risser at 8:47 PM
0 Comments:
Post a Comment
<< Home